Treatment Registry
TR-0586 ActiveRecorded September 2, 2026

Unspecified GLP-1

Sold by Ryze Rx · every unspecified glp-1 record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$119

Medication · Starting price, site banner$119

Added from the figures recorded below.

Price

TermPer monthCharged today
Starting price, site banner

GLP-1s from $119/mo | Testosterone from $89/mo

source

Per month$119Charged today$119
Starting price, Weight Loss treatment card (contradicts the $119/mo banner)

Most Popular Weight Loss GLP-1 medications for lasting results From $149/mo

source

Per month$149Charged today$149
Visit Ryze Rx

We earn nothing from this link. Ryze Rx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

StatesNot disclosed as of September 3, 2026
Cancellation“Subscription plans renew automatically until cancelled; you may cancel at any time before your next renewal date by contacting support@ryzerx.com.”

Not yet checked: pharmacy, prescriber, membership and consult fee.

Recorded from joinryzerx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Neither semaglutide nor tirzepatide is ever named specifically for weight loss -- the site only markets generic 'GLP-1s,' so the drug value is recorded as unspecified GLP-1. The homepage banner ($119/mo) and the mid-page Weight Loss treatment card ($149/mo) give two different starting prices for the same offer. 'Prices are shown at checkout and may change' per the Terms page, so neither figure is a confirmed final price.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0586
Readings
1

Related records

Unspecified GLP-1 at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 72 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Ryze Rx unspecified GLP-1 (TR-0586). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0586

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.